← Back to summaries

ABBV

Abbvie Inc
Healthcare · Drug Manufacturers - General · Data as of 2026-03-20
$205.12
SMA 20
SMA 50
SMA 200

📊 Valuation

Forward P/E12.7
Trailing P/E86.9
PEG Ratio0.59
Market Cap362.68B
Target Price$255.27

📈 Technicals

Trenddowntrend
RSI (14)28
Rel. Strength Rank37%
Above 50 SMA❌
Above 200 SMA❌

💰 Fundamentals

EPS (TTM)2.36
ROE15221.82%
Profit Margin6.84%
Dividend6.65 (3.24%)

🎯 Strategy Analysis

price-action 70 - WATCH
  • Eligible asset class for price action.
  • Clear market structure present.
  • Price at supply/demand zone.
  • No liquidity sweep detected.
  • Volume not confirming.
Value Momentum 65 - WATCH
  • Eligible asset class.
  • Intermediate trend does not confirm.
  • Liquidity clears threshold.
  • Price is below the 200 SMA.
  • Relative strength is weak.
iron-condor 50 - FAIL
  • Eligible asset class for iron condor.
  • Live option-chain inputs unavailable.
  • Stock is trending - iron condor less ideal.
  • No earnings within DTE window.
  • Support and resistance levels defined for wing placement.
Covered Call / CSP 48 - FAIL
  • Eligible equity underlying.
  • No listed options available.
  • Underlying/options liquidity is acceptable.
  • Underlying is acceptable to own on assignment.
  • Support/resistance anchors exist for strike selection.
Bounce / Swing 35 - FAIL
  • Eligible equity for bounce/swing.
  • Trend context does not support bounce setup.
  • No pullback/consolidation pattern detected.
  • Support and resistance are defined.
  • Liquidity clears swing-trade threshold.